Allurion Technologies, Inc.

NYSE:ALUR USA Medical Devices
Market Cap
$7.37 Million
Market Cap Rank
#33299 Global
#10880 in USA
Share Price
$0.60
Change (1 day)
+57.89%
52-Week Range
$0.26 - $3.58
All Time High
$10.69
About

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehea… Read more

Allurion Technologies, Inc. (ALUR) - Total Liabilities

Latest total liabilities as of September 2025: $101.07 Million USD

Based on the latest financial reports, Allurion Technologies, Inc. (ALUR) has total liabilities worth $101.07 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Allurion Technologies, Inc. - Total Liabilities Trend (2020–2024)

This chart illustrates how Allurion Technologies, Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Allurion Technologies, Inc. Competitors by Total Liabilities

The table below lists competitors of Allurion Technologies, Inc. ranked by their total liabilities.

Company Country Total Liabilities
Discovery Lithium Inc.
PINK:DCLIF
USA $1.36 Million
Cinevista Limited
NSE:CINEVISTA
India ₹908.97 Million
HANSEYACHTS
HM:H9Y
Germany €115.73 Million
SATO Technologies Corp
V:SATO
Canada CA$7.52 Million
CIENA - Dusseldorf Stock Exchang
DU:CIE1
Germany €2.68 Billion
Callan JMB Inc. Common Stock
NASDAQ:CJMB
USA $3.56 Million
Charn Issara Development Public Company Limited
BK:CI
Thailand ฿8.16 Billion

Liability Composition Analysis (2020–2024)

This chart breaks down Allurion Technologies, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.26 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.22 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 5.57 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Allurion Technologies, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Allurion Technologies, Inc. (2020–2024)

The table below shows the annual total liabilities of Allurion Technologies, Inc. from 2020 to 2024.

Year Total Liabilities Change
2024-12-31 $110.79 Million -22.09%
2023-12-31 $142.20 Million +69.92%
2022-12-31 $83.68 Million +13.65%
2021-12-31 $73.64 Million +23643.29%
2020-12-31 $310.13K --